跳至主要内容
临床试验/NCT04647019
NCT04647019已完成不适用

The Effects of Wild Blueberries on Depressive Symptoms in Young Adults: a Randomized, Double-blind, Placebo-controlled Trial

University of Reading2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年11月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
2
主要终点
Beck Depression Inventory-II (BDI-II)

研究概览

简要总结

This study aims to investigate the effects of a 6-week dietary intervention of 22 g freeze-dried whole wild blueberry powder. The outcomes include measures of depression, anxiety, anhedonia, cognitive function, and biomarkers of inflammation and oxidative stress.

详细描述

A randomized, double-blind, placebo-controlled, parallel-design study assessing the effects of a 6-week intervention of wild blueberry powder in young adults with depressive symptoms. A total of 60 participants will be randomly assigned to either 22 g blueberry powder or a matched placebo powder consumed daily with water. The severity of depression, anxiety, anhedonia, perceived stress, and quality of life will be measured at baseline and 6 weeks later. In addition, we will assess changes in cognitive function and transient mood 2 hours after consuming a single dose of blueberries.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 24 years of age
  • Patient Health Questionnaire-9 score ≥ 10 and a score ≥ 2 on the sum of items 1 and 2
  • Willingness to provide blood samples

排除标准

  • Any medically significant condition (e.g. diabetes, endocrine or gastrointestinal disorders)
  • Taking medication (excluding hormonal contraception)
  • History of mental illness (excluding anxiety and unipolar depressive disorders)
  • Allergy to blueberries or any other Vaccinium species
  • Receiving psychotherapy or counselling

结局指标

主要结局

Beck Depression Inventory-II (BDI-II)

时间窗: 6 weeks

A validated 21-item self-rated scale for assessing depression severity. The scale ranges from 0 to 63 points with higher scores indicating more severe depressive symptomatology.

次要结局

  • Snaith-Hamilton Pleasure Scale (SHAPS) - modified version(6 weeks)
  • Brain-derived neutrophic factor (BDNF) in serum(6 weeks)
  • Negative affect as measured by PANAS-X(6 weeks)
  • Cognitive flexibility(6 weeks)
  • Serum superoxide dismutase (SOD)(6 weeks)
  • Serum total antioxidant capacity (TAC)(6 weeks)
  • Patient Health Questionnaire-9 (PHQ-9)(6 weeks)
  • Composite Quality of Life Index(6 weeks)
  • Positive affect as measured by PANAS-X(6 weeks)
  • Interleukin-6 (IL-6) in serum(6 weeks)
  • Uric acid in serum(6 weeks)
  • Generalized Anxiety Disorder 7-item Scale (GAD-7)(6 weeks)
  • Perceived Stress Scale (PSS-10)(6 weeks)
  • C-reactive protein (CRP) in serum(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof Claire Williams

Professor

University of Reading

研究点 (2)

Loading locations...

相似试验